EPS for Mesa Laboratories, Inc. (MLAB) Expected At $0.85, Check Point Software Technologies Ltd. (CHKP) Had 8 Bullish Analysts

July 17, 2017 - By Winifred Garcia

Analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to report $0.85 EPS on July, 27.They anticipate $0.04 EPS change or 4.49% from last quarter’s $0.89 EPS. MLAB’s profit would be $3.19 million giving it 43.68 P/E if the $0.85 EPS is correct. After having $1.24 EPS previously, Mesa Laboratories, Inc.’s analysts see -31.45% EPS growth. It closed at $148.52 lastly. It is down 44.42% since July 17, 2016 and is uptrending. It has outperformed by 27.72% the S&P500.

Among 24 analysts covering Check Point Software Technologies Ltd. (NASDAQ:CHKP), 8 have Buy rating, 2 Sell and 14 Hold. Therefore 33% are positive. Check Point Software Technologies Ltd. had 37 analyst reports since September 10, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, June 16 by Deutsche Bank. Wells Fargo initiated the stock with “Outperform” rating in Wednesday, January 11 report. The firm has “Buy” rating given on Tuesday, February 7 by BTIG Research. The stock has “Buy” rating by Jefferies on Tuesday, May 30. Jefferies maintained it with “Buy” rating and $118 target in Wednesday, January 18 report. BMO Capital Markets maintained Check Point Software Technologies Ltd. (NASDAQ:CHKP) on Friday, January 20 with “Market Perform” rating. On Thursday, April 21 the stock rating was maintained by UBS with “Neutral”. The rating was maintained by Wells Fargo on Thursday, September 17 with “Outperform”. Northland Capital maintained the shares of CHKP in report on Thursday, June 29 with “Hold” rating. The stock has “Neutral” rating by BTIG Research on Thursday, September 10. See Check Point Software Technologies Ltd. (NASDAQ:CHKP) latest ratings:

14/07/2017 Broker: BMO Capital Markets Rating: Hold New Target: $117.0000 Maintain
07/07/2017 Broker: Jefferies Rating: Buy New Target: $126.0000 Maintain
29/06/2017 Broker: Northland Capital Rating: Hold New Target: $120.0000 Maintain
28/06/2017 Broker: Oppenheimer Rating: Buy New Target: $128.0000 Maintain
13/06/2017 Broker: Oppenheimer Rating: Buy New Target: $128.0000 Maintain
07/06/2017 Broker: Susquehanna Rating: Positive New Target: $132 Initiates Coverage On
01/06/2017 Broker: BMO Capital Markets Rating: Hold New Target: $117.0000 Maintain
30/05/2017 Broker: Jefferies Rating: Buy New Target: $126.0000 Maintain
29/05/2017 Broker: RBC Capital Markets Rating: Hold New Target: $105.0000 Maintain
14/03/2017 Broker: Monness Crespi & Hardt Rating: Neutral Initiates Coverage On

Check Point Software Technologies Ltd. develops, markets and supports a range of services and products for information technology (IT) security. The company has market cap of $18.95 billion. The Company’s services and products are sold to enterprises, service providers, small and medium sized businesses and consumers. It has a 26.36 P/E ratio. It offers enterprises a platform to deploy independent, modular and interoperable security applications (Software Blades), such as firewall, virtual private network (VPN), intrusion prevention system (IPS), Application Control, Anti-Bot, antivirus, data loss prevention (DLP), policy management, event analysis or multi-domain management.

It closed at $114.08 lastly. It is down 31.64% since July 17, 2016 and is uptrending. It has outperformed by 14.94% the S&P500.

Mesa Laboratories, Inc. is focused primarily on quality control services and products. The company has market cap of $557.59 million. The Firm operates through four divisions: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. It has a 51.11 P/E ratio. The Instruments Division designs, makes and markets quality control instruments and disposable products.

Since February 6, 2017, it had 0 insider purchases, and 10 sales for $7.25 million activity. Another trade for 5,922 shares valued at $734,269 was made by Sullivan John James on Monday, February 13. $245,800 worth of stock was sold by Schmieder John Bradley on Tuesday, February 7. The insider Adriance Glenn E sold $1.00 million. 8,000 shares were sold by CAMPBELL H STUART, worth $972,400 on Tuesday, February 7. KELLY DAVID M had sold 1,000 shares worth $142,000 on Monday, June 12. 11,150 Mesa Laboratories, Inc. (NASDAQ:MLAB) shares with value of $1.55M were sold by Dwyer Robert V. 2,000 shares were sold by BROOKS MICHAEL T, worth $245,880.

Investors sentiment increased to 2.42 in Q4 2016. Its up 0.96, from 1.46 in 2016Q3. It improved, as 2 investors sold Mesa Laboratories, Inc. shares while 17 reduced holdings. 10 funds opened positions while 36 raised stakes. 2.16 million shares or 4.36% more from 2.07 million shares in 2016Q3 were reported. Neuberger Berman Gp Ltd Company invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Ativo Cap Mgmt Llc owns 8,020 shares or 0.23% of their US portfolio. King Luther Capital Mngmt has invested 0.02% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Crawford Investment Counsel reported 0.12% stake. Rocky Mountain Advisers Ltd holds 0.3% in Mesa Laboratories, Inc. (NASDAQ:MLAB) or 500 shares. Swiss Bancorp holds 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB) or 5,202 shares. California State Teachers Retirement System holds 6,192 shares. Us Natl Bank De reported 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Bahl And Gaynor Incorporated holds 0.01% or 8,785 shares. Ranger Mgmt Limited Partnership has 13,190 shares. Punch Investment Management Inc owns 21,210 shares. Bb&T reported 0.01% stake. Schwab Charles Inv Management accumulated 4,800 shares. Rhumbline Advisers holds 0% or 3,530 shares in its portfolio. Citigroup Inc invested in 3,040 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: